198 related articles for article (PubMed ID: 32244387)
21. Etamycin as a Novel
Hanh BTB; Kim TH; Park JW; Lee DG; Kim JS; Du YE; Yang CS; Oh DC; Jang J
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32967077
[TBL] [Abstract][Full Text] [Related]
22. Active Benzimidazole Derivatives Targeting the MmpL3 Transporter in
Raynaud C; Daher W; Johansen MD; Roquet-Banères F; Blaise M; Onajole OK; Kozikowski AP; Herrmann JL; Dziadek J; Gobis K; Kremer L
ACS Infect Dis; 2020 Feb; 6(2):324-337. PubMed ID: 31860799
[TBL] [Abstract][Full Text] [Related]
23. Antimycobacterial activity of nonantibiotics associated with the polypharmacy of cystic fibrosis (CF) against mycobacterium abscessus.
Kirkwood ZI; Millar BC; Downey DG; Moore JE
Int J Mycobacteriol; 2018; 7(4):358-360. PubMed ID: 30531035
[TBL] [Abstract][Full Text] [Related]
24. Alternative and Experimental Therapies of
Meir M; Barkan D
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32948001
[No Abstract] [Full Text] [Related]
25. A Screening of the MMV Pandemic Response Box Reveals Epetraborole as a New Potent Inhibitor against
Kim T; Hanh BT; Heo B; Quang N; Park Y; Shin J; Jeon S; Park JW; Samby K; Jang J
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073006
[No Abstract] [Full Text] [Related]
26. Assessment of Clofazimine and TB47 Combination Activity against Mycobacterium abscessus Using a Bioluminescent Approach.
Liu Y; Tan Y; Islam MM; Cao Y; Lu X; Zeng S; Hameed HMA; Zhou P; Cai X; Wang S; Mugweru JN; Zhang G; Yin H; Liu J; Nuermberger E; Zhang T
Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31843996
[No Abstract] [Full Text] [Related]
27. Repurposing disulfiram to target infections caused by non-tuberculous mycobacteria.
Das S; Garg T; Chopra S; Dasgupta A
J Antimicrob Chemother; 2019 May; 74(5):1317-1322. PubMed ID: 30753528
[TBL] [Abstract][Full Text] [Related]
28. Rifabutin Is Active against Mycobacterium abscessus Complex.
Aziz DB; Low JL; Wu ML; Gengenbacher M; Teo JWP; Dartois V; Dick T
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28396540
[TBL] [Abstract][Full Text] [Related]
29. TBAJ-876, a 3,5-Dialkoxypyridine Analogue of Bedaquiline, Is Active against Mycobacterium abscessus.
Sarathy JP; Ganapathy US; Zimmerman MD; Dartois V; Gengenbacher M; Dick T
Antimicrob Agents Chemother; 2020 Mar; 64(4):. PubMed ID: 31964791
[TBL] [Abstract][Full Text] [Related]
30. Efficacy of Moxifloxacin against
Nie WJ; Xie ZY; Gao S; Teng TL; Zhou WQ; Shang YY; Jing W; Shi WH; Wang QF; Huang XR; Cai BY; Wang J; Wang J; Guo R; Ge QP; Nie LH; Han XQ; Du YD; Chu NH
Biomed Environ Sci; 2020 May; 33(5):350-358. PubMed ID: 32553079
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of Anti-Mycobacterial Compounds in a Silkworm Infection Model with
Hosoda K; Koyama N; Hamamoto H; Yagi A; Uchida R; Kanamoto A; Tomoda H
Molecules; 2020 Oct; 25(21):. PubMed ID: 33121091
[TBL] [Abstract][Full Text] [Related]
32. Bedaquiline Inhibits the ATP Synthase in Mycobacterium abscessus and Is Effective in Infected Zebrafish.
Dupont C; Viljoen A; Thomas S; Roquet-Banères F; Herrmann JL; Pethe K; Kremer L
Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807917
[TBL] [Abstract][Full Text] [Related]
33. Verapamil Improves the Activity of Bedaquiline against Mycobacterium abscessus In Vitro and in Macrophages.
Viljoen A; Raynaud C; Johansen MD; Roquet-Banères F; Herrmann JL; Daher W; Kremer L
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31209005
[TBL] [Abstract][Full Text] [Related]
34. Clomiphene Citrate Shows Effective and Sustained Antimicrobial Activity against
Lee DG; Hwang YH; Park EJ; Kim JH; Ryoo SW
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681686
[No Abstract] [Full Text] [Related]
35. Treatment of infection-induced vascular pathologies is protective against persistent rough morphotype Mycobacterium abscessus infection in zebrafish.
Kam JY; Wright K; Britton WJ; Oehlers SH
Microb Pathog; 2022 Jun; 167():105590. PubMed ID: 35588967
[TBL] [Abstract][Full Text] [Related]
36. Indole-2-Carboxamides Are Active against
Pandya AN; Prathipati PK; Hegde P; Li W; Graham KF; Mandal S; Drescher KM; Destache CJ; Ordway D; Jackson M; North EJ
Antimicrob Agents Chemother; 2019 Mar; 63(3):. PubMed ID: 30602519
[TBL] [Abstract][Full Text] [Related]
37. Auranofin Activity Exposes Thioredoxin Reductase as a Viable Drug Target in
Ruth MM; van Rossum M; Koeken VACM; Pennings LJ; Svensson EM; Ruesen C; Bowles EC; Wertheim HFL; Hoefsloot W; van Ingen J
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262763
[TBL] [Abstract][Full Text] [Related]
38. Mycobacteriological characteristics and treatment outcomes in extrapulmonary Mycobacterium abscessus complex infections.
Jeong SH; Kim SY; Huh HJ; Ki CS; Lee NY; Kang CI; Chung DR; Peck KR; Shin SJ; Koh WJ
Int J Infect Dis; 2017 Jul; 60():49-56. PubMed ID: 28522316
[TBL] [Abstract][Full Text] [Related]
39. Antimycobacterial activity of veterinary antibiotics (Apramycin and Framycetin) against
Moore JE; Koulianos G; Hardy M; Misawa N; Millar BC
Int J Mycobacteriol; 2018; 7(3):265-267. PubMed ID: 30198508
[TBL] [Abstract][Full Text] [Related]
40. Mycobacterium tuberculosis DprE1 Inhibitor OPC-167832 Is Active against Mycobacterium abscessus
Sarathy JP; Zimmerman MD; Gengenbacher M; Dartois V; Dick T
Antimicrob Agents Chemother; 2022 Dec; 66(12):e0123722. PubMed ID: 36350151
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
